Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Guest post: Looking out for the invisibly vulnerable in the time of COVID-19

By Guest Contributor  |    March 26, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Nearly 140 medicines in development to treat mental illness

By Andrew Powaleny  |    October 10, 2019
Today is World Mental Health Day, a moment where we reflect about the challenges we still face towards better treatment of mental illness and its impact on patients.   Read More

Mental health in the New Era of Medicine

By Bill Chin, M.D.  |    April 18, 2017
Research and development of innovative medicines to promote mental health are a priority for America’s biopharmaceutical research companies. With more than 130 medicines in development for mental...   Read More

Burden on patients: Access to medicines in health insurance exchange plans

By Allyson Funk  |    June 23, 2016
Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still...   Read More

Cost of mental illness underscores need for new treatments

By Holly Campbell  |    May 25, 2016
Today, one in five American adults and children experience a mental illness in any given year. As the prevalence of complex mental health conditions has grown, the cost of caring for patients has...   Read More

Highlighting innovation during Mental Illness Awareness Week 2015

By Hannah Mooney  |    October 6, 2015
Each year, during the first full week of October, organizations across the country work to raise awareness for mental health disorders to educate the public, fight stigma and provide support....   Read More

Medicare Monday: Research Finds Access to Medicare Prescription Drug Coverage Improved Health Outcomes, Significantly Reducing Depressive Symptoms Among Seniors

By Andrew Powaleny  |    August 10, 2015
Depression in the U.S. affects more than 6.5 million Americans age 65 and older. The Medicare Part D prescription drug benefit provides seniors and people living with disabilities access to...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    June 19, 2015
Burden on Patients: Access to medicines is important for patients who are managing chronic conditions. In the latest edition of the ”Burden on Patients” series, we’re taking a look at the barriers...   Read More

Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans

By Allyson Funk  |    June 18, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to mental...   Read More

We Must Work Together to Lessen the Toll of Mental Illness

By Guest Contributor  |    October 8, 2014
Mental Illness Awareness Week, which takes place the first full week of October, is an opportunity to raise awareness of mental illness and make progress in eliminating stigmas that discourage...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates